You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (360Dx) – Oxford Immunotec and Qiagen said today that they have settled a lawsuit alleging patent infringement of Oxford's patents by Qiagen's QuantiFERON-TB Gold and QuantiFERON-TB Gold Plus blood tests for tuberculosis infection.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.